March 21 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. will transfer the listing of its American depositary shares to the New York Stock Exchange from the Nasdaq Global Select Market.
Teva will begin trading on the NYSE on May 30 under the same stock symbol, TEVA, the Petach Tikva, Israel-based company said in a statement today.
“As we continue to grow, the NYSE, the world’s largest stock exchange, will provide a state-of-the-art trading platform, as well as greater market reach,’’ Teva Chairman Phillip Frost said in the statement.
To contact the reporter on this story: Phil Serafino in Paris at email@example.com
To contact the editor responsible for this story: Phil Serafino at firstname.lastname@example.org